Evidence map›Paper›PMID 31015317›Full record

ArticleThe oncologist2019

Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.

Kah Poh Loh, Supriya G Mohile, Jennifer L Lund, Ronald Epstein, Lianlian Lei, Eva Culakova, Colin McHugh, Megan Wells, Nikesha Gilmore, Mostafa R Mohamed and 9 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04823754 (Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma), which is not on this map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04823754 completednot on this mapstarted 2021, after this paper: background citation

Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2021 to 2022Enrolled150ConditionsHepatocellular CarcinomaArmsHospitalized patient with advanced hepatocellular carcinoma receiving systemic therapy.
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Determining patient-oncologist cancer treatment intent concordance using systematic screening in a supportive care center.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Kah Poh LohJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA kahpoh_loh@urmc.rochester.edu.ORCID 0000-0002-6978-0418
Supriya G MohileJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0003-0867-327X
Jennifer L LundUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ronald EpsteinJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-3564-9163
Lianlian LeiDepartment of Public Health Services, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Eva CulakovaJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-9852-6515
Colin McHughJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0003-4437-3899
Megan WellsJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.
Nikesha GilmoreJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-5079-1723
Mostafa R MohamedJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.
Charles KamenJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-4219-4320
Valerie AarneJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.
Alison ConlinPacific Cancer Research Consortium NCORP, Seattle, Washington, USA.
James BeardenSoutheast Clinical Oncology Research Consortium NCORP, Winston-Salem, North Carolina, USA.
Adedayo OnitiloWisconsin NCORP, Weston, Wisconsin, USA.
Marsha WittinkDepartment of Psychiatry, Palliative Care, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-3037-9723
William DaleCity of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0001-9899-6413
Arti HurriaCity of Hope National Medical Center, Duarte, California, USA.
Paul DubersteinDepartment of Psychiatry, Palliative Care, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0001-6882-0898
University of Rochester Medical Center · USCity Of Hope National Medical Center · USRutgers, The State University of New Jersey · USSoutheast Clinical Oncology Research Consortium · USUniversity of North Carolina at Chapel Hill · USUniversity of Rochester · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
The Pacific Cancer Research Consortium (PCRC), an NCORP Community SiteUG1CA189953 · NCI · SWEDISH MEDICAL CENTER, FIRST HILL · PI Alison Katherine Conlin, Charles Drescher · 2014 to 2026
$27.4M
Reducing Chemotherapy Toxicity in Older AdultsR01CA177592 · NCI · UNIVERSITY OF ROCHESTER · PI MOHILE, SUPRIYA G. · 2013 to 2018
$3.0M
Impact of a Novel Cancer Communication Intervention on Caregiver BereavementR01CA168387 · NCI · UNIVERSITY OF ROCHESTER · PI DUBERSTEIN, PAUL R, PRIGERSON, HOLLY GWEN · 2013 to 2017
$2.6M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR21AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI DALE, WILLIAM, MOHILE, SUPRIYA G. · 2018 to 2019
$478k
NCI NIH HHS R01 CA168387NCI NIH HHS R01 CA177592NCI NIH HHS UG1 CA189953NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS R21 AG059206
6 · The paper itself

Abstract

backgroundEnsuring older patients with advanced cancer and their oncologists have similar beliefs about curability is important. We investigated discordance in beliefs about curability in patient-oncologist and caregiver-oncologist dyads. MATERIALS AND

methodsWe used baseline data from a cluster randomized trial assessing whether geriatric assessment improves communication and quality of life in older patients with advanced cancer and their caregivers. Patients were aged ≥70 years with incurable cancer from community oncology practices. Patients, caregivers, and oncologists were asked: "What do you believe are the chances the cancer will go away and never come back with treatment?" Options were 100%, >50%, 50/50, <50%, and 0% (5-point scale). Discordance in beliefs about curability was defined as any difference in scale scores (≥3 points were severe). We used multivariate logistic regressions to describe correlates of discordance.

resultsDiscordance was present in 60% (15% severe) of the 336 patient-oncologist dyads and 52% (16% severe) of the 245 caregiver-oncologist dyads. Discordance was less common in patient-oncologist dyads when oncologists practiced longer (adjusted odds ratio [AOR] 0.90, 95% confidence interval [CI] 0.84-0.97) and more common in non-Hispanic white patients (AOR 5.77, CI 1.90-17.50) and when patients had lung (AOR 1.95, CI 1.29-2.94) or gastrointestinal (AOR 1.55, CI 1.09-2.21) compared with breast cancer. Severe discordance was more common when patients were non-Hispanic white, had lower income, and had impaired social support. Caregiver-oncologist discordance was more common when caregivers were non-Hispanic white (AOR 3.32, CI 1.01-10.94) and reported lower physical health (AOR 0.88, CI 0.78-1.00). Severe discordance was more common when caregivers had lower income and lower anxiety level.

conclusionDiscordance in beliefs about curability is common, occasionally severe, and correlated with patient, caregiver, and oncologist characteristics. IMPLICATIONS FOR PRACTICE: Ensuring older patients with advanced cancer and their caregivers have similar beliefs about curability as the oncologist is important. This study investigated discordance in beliefs about curability in patient-oncologist (PO) and caregiver-oncologist (CO) dyads. It found that discordance was present in 60% (15% severe) of PO dyads and 52% (16% severe) of CO dyads, raising serious questions about the process by which patients consent to treatment. This study supports the need for interventions targeted at the oncologist, patient, caregiver, and societal levels to improve the delivery of prognostic information and patients'/caregivers' understanding and acceptance of prognosis.

Indexed as

Geriatric AssessmentPhysician-Patient RelationsAdultAgedAged, 80 and overAge FactorsCaregiversCommunicationFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedNeoplasmsOncologistsPrognosisBeliefs about cancer curabilityCaregiversDiscordanceOlder adultsOncologists

Identifiers

PMID31015317
PMCPMC6656513
OpenAlexW2942122773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.